COVID Vaccines and Kids: Five Questions as Trials Begin
Nature
![](/sites/default/files/styles/large/public/field/image/coronavirusChildren.jpg)
Vaccine trials will involve only a few thousand children, so there may be too few symptomatic infections to measure efficacy. It makes more sense to look at immune markers after vaccination.
Spread the word